HCL Technologies has signed an MoU with the Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at IIT, Delhi to work on high-end projects in the area of drug discovery and development including genomics and protemics projects.According to a release issued by HCL Tech to the BSE today, the company plans to team up with premier bioinformatics research institutions across the world to build fundamental capabilities and grow the Indian talent pool in the domain."The company will use its CMMI processes and robust software design methodology to leverage the domain expertise of the team at IIT, Delhi," the release added.SCFBio is dedicated to developing novel scientific methods and new software for genome analysis, protein structure prediction and active site-directed drug design. The partnership will also provide the researchers access to company's software development expertise, the release added.
